Benefit of uridine triacetate (Vistogard) in rescuing severe 5-fluorouracil toxicity in patients with dihydropyrimidine dehydrogenase (DPYD) deficiency
Crossref DOI link: https://doi.org/10.1007/s00280-016-3063-1
Published Online: 2016-06-08
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Saif, Muhammad Wasif
Diasio, Robert B.
Funding for this research was provided by:
NIH Clinical Center (NIH grant CA 62164)
Text and Data Mining valid from 2016-06-08
Version of Record valid from 2016-06-08
Article History
Received: 9 March 2016
Accepted: 11 May 2016
First Online: 8 June 2016